Diagnosis of Helicobacter pylori associated gastritis by serum pepsinogen levels

Diagnosis of Helicobacter pylori associated gastritis by serum pepsinogen levels - Pepsinogen and H.pylori gastritis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000011744

Enrollment

500

Registered

2013-09-13

Start date

2013-10-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter pylori associated gastritis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Endoscopic subjects who want to receive a Helicobacter pylori infection test and to take eradication treatment if its result is positive. Patients who give a written informed consent

Exclusion criteria

Exclusion criteria: Past history of allergy for the drugs used in this study. Past history of taking eradication therapy. Past history of gastrectomy. Gastric cancer patients, Pregnancy or lactation, Severe renal dysfunction ,Blood disease, Infectious Mononucleosis Patients who are disqualified for the study by their physicians

Design outcomes

Primary

Measure	Time frame
Comparison of the serum pepsinogen levels by presence or absence of H.pylori infection	—

Secondary

Measure	Time frame
Investigation of the changes of the serum pepsinogen levels by success of H.pylori eradication according to endoscopic atrophy and histologic gastritis before the eradication	—

Countries

Japan

Contacts

Public ContactKatsuhiro Mabe

Hokkaido University Hospital Division of Endoscopy

kmabe@med.hokudai.ac.jp011-716-1161

Outcome results